← Leaderboards
Caroline L Ng
University Of Nebraska Medical Center
$1,913,123
Attributed
$1,913,123
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $747.6K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,913,123 · 2
By mechanism
R01$1,493,872 · 1
R21$419,251 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Saraswathi Viswanathan$2,460,414
Others in their field
Other Emerging Leaders on “Plasmodium Falciparum”
- Tuan Manh Tran · Indiana University Indianapolis$5,928,110
- Beyene Petros · University Of California-Irvine$5,007,087
- Jennifer Manuzak · University Of Washington$4,672,308
- Evelien Margaretha Bunnik · University Of Texas Hlth Science Center$4,122,427
- Ross Mathew Boyce · Univ Of North Carolina Chapel Hill$4,086,218
- Facundo Damian Batista · Massachusetts General Hospital$3,603,389
Research focus
Plasmodium FalciparumResponseMolecularPathway InteractionsProtein DegradationResistanceHemeMediatingMutationParasitesAffectProteasome InhibitorFalciparum MalariaProteinsAfricaFutureMalariaCessation Of LifeArtemisininsMulticatalytic Endopeptidase ComplexCombatParasite ResistanceCombined Modality TherapySignal Transduction
Grant awards (4)
Proteostasis in Plasmodium falciparum artemisinin resistance$747,604
R01 · FY2025 · AI · contact PI
Proteostasis in Plasmodium falciparum artemisinin resistance$746,268
R01 · FY2024 · AI · contact PI
Leveraging insights into the Plasmodium falciparum ubiquitin-proteasome system and the unfolded protein response to combat artemisinin resistance through synergistic combinations$190,625
R21 · FY2019 · AI · contact PI
Leveraging insights into the Plasmodium falciparum ubiquitin-proteasome system and the unfolded protein response to combat artemisinin resistance through synergistic combinations$228,626
R21 · FY2018 · AI · contact PI